HOME >> BIOLOGY >> NEWS
Gastrointestinal specialists comment on new study on 'Virtual' colonoscopy

Arlington, VA, December 1, 2003 New colorectal cancer screening strategies, including virtual colonoscopy and fecal DNA testing, offer the potential to enhance the acceptability of colorectal cancer screening to some persons. Virtual colonoscopy has not yet been endorsed by any multidisciplinary guideline group as an effective colorectal cancer screening strategy. The principle obstacle to endorsement thus far has been the wide range and frequent lack of effectiveness in clinical trials.

The American College of Gastroenterology congratulates the investigators of a new study on virtual colonoscopy that will appear in the New England Journal of Medicine next week. The results represent a remarkable improvement on previous results. The results appear to rest on fundamental changes in the method of performance of virtual colonoscopy. Excellent results have been seen in some previous studies that could not be repeated by others. It will be important to verify these results to confirm their generalizability.

Conventional colonoscopy is itself a dynamic technology. Improvements in bowel preparation, sedation and sensitivity for adenomas are being actively investigated and developed.

"Considering all available literature, conventional colonoscopy as currently performed remains the clear gold standard for the diagnosis of colorectal cancer and adenomas. Patients should be aware that in this study of virtual colonoscopy and in some others, they are more likely to experience significant discomfort with virtual colonoscopy than they are with conventional colonoscopy," stated Douglas K. Rex, M.D., FACG, President of the American College of Gastroenterology and Director of Endoscopy at Indiana University Hospital in Indianapolis, IN.

As was demonstrated in the NEJM study, at least 30 percent of patients (in some studies higher percentages) undergoing virtual colonoscopy will require conventional colonoscopy to remove polyps 6mm or large
'"/>

Contact: Anne-Louise Oliphant
aloliphant@acg.gi.org
703-820-7400
Porter Novelli
1-Dec-2003


Page: 1 2

Related biology news :

1. Difficulties with primate cloning: A religious comment
2. UGA researcher comments on her teams discovery of the first jumping genes in rice
3. ViaCell Inc., the worlds largest umbilical cord blood research and banking company comments on Bush administrations decision
4. Federal government makes final call for data, public comment before writing new report on cancer-causing substances
5. AAAS seeks public comment on stem cell research recommendation meeting on August 25th
6. Student science contest participation influences study, career choices, alumni say
7. New study shows hope for treating inhalant abuse
8. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
9. Cigarette smoke causes breaks in DNA and defects to a cells chromosomes, Pitt study finds
10. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
11. Phase II trials of second-generation antisense cancer drug planned following successful early study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... 27, 2020 , ... CrucialTrak, a global designer and manufacturer of biometric access ... (CEG) to market and sell its complete line of biometric readers and access ... infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales for ...
(Date:5/28/2020)... ... May 28, 2020 , ... Actuate Therapeutics, ... their 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will be presented at ... place virtually on May 29th, 2020. Dr. Benedito Carneiro, Brown University’s principal investigator ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... background and medical screening, announces the launch of a testing service aimed ... safe. The new service is provided by ClearStar’s Medical Information Services (“MIS”) ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... 23, 2020 , ... Kerafast Inc. , developers of ... the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, ... SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., announced today ... 22-24 during the American Association for Cancer Research Virtual meeting. One poster describes ... consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
(Date:6/11/2020)... ... , ... Greffex, a leading genetic engineering company, with the ... vectors, recently announced a key manufacturing agreement with FUJIFILM Diosynth Biotechnologies to produce ... successful gene therapy delivery vehicle (vector) with broad applications for delivering treatments including ...
(Date:6/11/2020)... ... 2020 , ... Reducing carbon emissions has been and will continue to be ... market dips, ways to reduce CO2 is something we can’t avoid. , To ... biofuels being produced today are created from recycled cooking oil or crops. Unfortunately, these ...
Breaking Biology Technology:
Cached News: